Caliber Wealth Management, LLC Oncocyte Corp Transaction History

Caliber Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$1.15 - $2.25 $241 - $472	-210 Reduced 0.28%	75,120 $112,000
Q4 2021 Jan 20, 2022	BUY	$2.04 - $3.59 $18,625 - $32,776	9,130 Added 13.79%	75,330 $142,000
Q3 2021 Oct 25, 2021	BUY	$3.53 - $5.89 $21,797 - $36,370	6,175 Added 10.29%	66,200 $218,000
Q1 2021 Apr 26, 2021	BUY	$2.39 - $6.5 $61,088 - $166,140	25,560 Added 74.16%	60,025 $312,000
Q4 2020 Jan 19, 2021	BUY	$1.38 - $2.63 $47,561 - $90,642	34,465 New	34,465 $82,000

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $246M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Caliber Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caliber Wealth Management, LLC with notifications on news.